Squadra Avocats has recently advised MAASH group in its takeover of METEX NØØVISTA.
A subsidiary of METabolix Explorer and a leader in the production, by fermentation, of naturally sourced ingredients for use in animal feed, cosmetics, and the biopolymer industry, Metex Nøøvista has been taken over by the Belgian company, Maash, as part of a restructuring procedure.
Metex Nøøvista forms part of Metex group, which uses fermentation to produce naturally sourced ingredients for animal feed and cosmetic products.
Listed on the Paris stock exchange, METabolix Explorer is responsible for carrying out the group’s research and development activities, as well as its financial activities as a holding company, and holds total ownership of its two operational subsidiaries: METEX NøøvistaGo, which operates a factory that produces amino acids through the fermentation of sugar; and METEX Nøøvista, created in 2018, which has, since March 2021, operated a newly constructed factory situated in Saint-Avold (in Lorraine), capable of producing up to 5000 tonnes of naturally sourced propanediol and up to 1000 tonnes of naturally sourced butyric acid.
METEX Nøøvista was required to open up judicial reorganisation proceedings following a ruling on the 25th of March 2024 from the Paris Commercial Court. A judgement from the Paris Commercial Court on the 25th of June 2024 authorised the handover of METEX Nøøvista’s assets and business activity to Maash.
Squadra Avocats was represented by Charles Morel and Emilie Rosier.
NULLSquadra (Charles Morel et Emilie Rosier) has recently supported the companies GRAFTYS and BIOLOGICS 4 LIFE in their insolvency proceedings before the Aix-en-Provence Commercial Court.
Graftys specialises in the development of bioresorbable synthetic bone grafts for orthopedic surgery. After carrying out research on biomaterials, the company created a new type of synthetic bone graft, that can be easily injected into the centre of bones in order to repair them. Graftys is now a market leader and has received particular recognition for its work in the US.
In 2021, it acquired another French medtech company, Biologics 4 Life, working in a similar field: the development of injectable biomaterials combined with active ingredients capable of treating and preventing fractures caused by osteoporosis.
Due to a now-resolved regulatory constraint., Graftys had to suspend activity for a number of months in 2023. Faced with financial difficulties at the beginning of 2024, it was necessary for the companies to enter into insolvency proceedings.
Morgane Mondolfo, partner at Squadra Avocats, has been interviewed by Décideurs Magazine about the EU’s Corporate Sustainability Reporting Directive (CRSD). This episode of HR Makers, hosted by Elsa Guérin and broadcasted by 4Change and DÉCIDEURS RH, considers the regulatory framework of the directive and examines how it will be implemented by HR departments. Morgane appeared in the interview alongside Laurence Breton-Keuny, HR Manager for AFNOR Group and Vice-President of ANDRH.
The interview is available to watch here, or by searching “HR Makers #2 – CSRD, qu’est-ce que cela change?” on YouTube.
#SquadraAvocats #avocats
NULLA few months after the promotion of Camille Mirabel-Chambaud to partner, Squadra Avocats seeks to strengthen its M&A / Private Equity department by welcoming a new partner, Olivier Mourain, to the team. Accompanied by a senior associate, he will support the six-person team of lawyers.
Olivier works with small and mid-cap clients, both French and international, as well as investment funds – assisting them through all their capital transactions, be it mergers and acquisitions, private equity, or restructuring. His clients mainly operate in the fields of software, healthcare, blockchain, and renewable energy.
He holds over fifteen years’ experience in his areas of expertise and has been recognised with numerous awards – notably for his work in Mergers & Acquisitions and Private Equity.
After graduating from Paris V University with an Advanced Diploma in Accounting and Management and an M.Phil in Civil and Commerical Law, he joined Fuchs, Cohana, Reboul et Associés at its creation in 2007, before becoming a partner in 2017.
He joins Squadra Avocats in order to offer his clients the benefit of a complete range of services, a comprehensive approach to cases, and a structured team skilled in handling transactional issues.
“Joining Squadra enables me to offer a comprehensive approach to my clients for their everyday problems and for the structural projects their development necessitates. I am delighted to be joining a team that is efficient and fast-growing, with strong ambitions and a real entrepreneurial spirit”, explains Olivier Mourain.
“Strengthening our M&A/Private Equity team was one of our priorities for 2024. The arrival of Olivier will allow us to broaden the scope of our offering and to develop our client base even further, while continuing to perform highly and receive industry recognition for the quality of our teams’ work. We are thrilled”, adds François Lan, the partner in charge of the department.
Squadra’s M&A / Private Equity team will soon be completed by the arrival of new associates to support its work.
NULLSquadra Avocats (François Lan, Camille Mirabel-Chambaud et Clément Salaün) has supported Siello in negotiating and securing pre-seed funding of €500.000.
These funds will allow for an acceleration in Siello’s development and progress towards its goal of creating custom technology to facilitate real estate transactions 🏘
Congratulations to Siello and its founders on this great deal!
#deal
#commerciallaw
#privateequity
#capital
#growth
#fundraising
#squadraavocats
Squadra Avocats (François Lan, Camille Mirabel-Chambaud) has supported KaryonFood in negotiating and securing seed funding of €1.3 million.
KaryonFood has created software to facilitate the exchange of data between food-processing companies (small, mid, and large cap) and distributors (large retailers or companies in the food service industry).
Congratulations to Claire Guillet, founder of KaryonFood, on this great deal!
#deal
#commerciallaw
#privateequity
#capital
#growth
#fundraising
#squadraavocats
Tereos and Futerro have paired up to develop, in Normandy, a circular and sustainable bio-industrial platform, committed to green chemistry.
The aim is to extract dextrose from sustainably-produced French wheat, before then transforming it, in the same geographical region, into bio-sourced, industrially compostable, and recyclable plastic. It’s in the industrial-port area of Port-Jérôme-Sur-Seine (76) that this unique initiative is set to begin in 2027.
Plant-based chemistry, renewability, decarbonization, innovation in maximizing agricultural value… this partnership represents a big step towards the bio-industrial world of the future.
About TEREOS
A cooperative group made up of over 11,200 members, Tereos is recognized for its expertise in the processing of beetroot, sugar cane, lucerne, grains, and potatoes. Thanks to its 43 industrial sites, an operating presence in 15 countries, and the efforts of its 15800 associates, Tereos matches its customers’ demands as closely as possible, with an extensive and complementary range of products.
In 2022/23, Tereos achieved sales of over €6,6 billion.
Squadra Avocats (Camille Mirabel-Chambaud et Marine Despres) has supported PERIPHERAL in negotiating and securing this funding.
PERIPHERAL channels visual information into the user’s peripheral vision, where it is subconsciously picked up by the brain’s subcortical nervous system and used to guide or inform people moving around under intense stress or cognitive load (like firefighters, for example).
Congratulations to founders Aymar de la Mettrie and Lionel Doyen on this great deal!
#deal
#commerciallaw
#privateequity
#capital
#growth
#fundraising
#squadraavocats
